SC
CERE

Sophrosyne Capital’s CERES, INC. COMMON STOCK NEW CERE Stock Holding History

Sophrosyne Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,125
Closed -$37K – 85
2013
Q3 		$37K Buy
+3,125
New +$42.9K 0.02% 66

Other funds holding CERE

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sophrosyne Capital's CERE Position: Q4 2013 in Review

Sophrosyne Capital sold out of CERES, INC. COMMON STOCK NEW (CERE) in Q4 2013, closing a stake of 3,125 shares — an estimated $37K sold.

Sophrosyne Capital first reported a position in CERE in Q3 2013 and held it in 1 quarter. The position peaked at $37K in Q3 2013. 26 funds tracked by Wall St. Rank hold CERE as of Q4 2013.

  • Sophrosyne Capital reported no remaining CERES, INC. COMMON STOCK NEW position as of Q4 2013 after selling out during the quarter.
  • Sophrosyne Capital sold 3,125 CERES, INC. COMMON STOCK NEW shares in Q4 2013, an estimated $37K.
  • Sophrosyne Capital first reported a position in CERES, INC. COMMON STOCK NEW in Q3 2013 and held it in 1 quarter.
  • Sophrosyne Capital's CERES, INC. COMMON STOCK NEW position peaked at $37K in Q3 2013.
  • 26 funds tracked by Wall St. Rank held CERES, INC. COMMON STOCK NEW as of Q4 2013.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.